Morgan Stanley’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.6K | Sell |
|
|||||
|
2025
Q1 | $106K | Sell |
|
|||||
|
2024
Q4 | $272K | Buy |
|
|||||
|
2024
Q3 | $214K | Buy |
|
|||||
|
2024
Q2 | $695K | Buy |
|
|||||
|
2024
Q1 | $553K | Sell |
|
|||||
|
2023
Q4 | $1.01M | Buy |
|
|||||
|
2023
Q3 | $286K | Sell |
|
|||||
|
2023
Q2 | $444K | Sell |
|
|||||
|
2023
Q1 | $944K | Buy |
|
|||||
|
2022
Q4 | $431K | Sell |
|
|||||
|
2022
Q3 | $370K | Buy |
|
|||||
|
2022
Q2 | $234K | Buy |
|
|||||
|
2022
Q1 | $104K | Sell |
|
|||||
|
2021
Q4 | $184K | Sell |
|
|||||
|
2021
Q3 | $390K | Buy |
|
|||||
|
2021
Q2 | $170K | Buy |
|
|||||
|
2021
Q1 | $35K | Buy |
|
|||||
|
2020
Q4 | $26K | Sell |
|
|||||
|
2020
Q3 | $327K | Buy |
|
|||||
|
2020
Q2 | $11K | Buy |
|
|||||
|
2020
Q1 | $3K | Buy |
|
|||||
|
2019
Q4 | $3K | Sell |
|
|||||
|
2019
Q3 | $3K | Hold |
|
|||||
|
2019
Q2 | $3K | Sell |
|
|||||
|
2019
Q1 | $7K | Sell |
|
|||||
|
2018
Q4 | $6K | Sell |
|
|||||
|
2018
Q3 | $12K | Buy |
|
|||||
|
2018
Q2 | $10K | Sell |
|
|||||
|
2018
Q1 | $6K | Sell |
|
|||||
|
2017
Q4 | $16K | Sell |
|
|||||
|
2017
Q3 | $15K | Buy |
|
|||||
|
2017
Q2 | $32K | Sell |
|
|||||
|
2017
Q1 | $40K | Sell |
|
|||||
|
2016
Q4 | $40K | Sell |
|
|||||
|
2016
Q3 | $118K | Buy |
|
|||||
|
2016
Q2 | $136K | Buy |
|
|||||
|
2016
Q1 | $117K | Sell |
|
|||||
|
2015
Q4 | $191K | Buy |
|
|||||
|
2015
Q3 | $76K | Sell |
|
|||||
|
2015
Q2 | $199K | Buy |
|
|||||
|
2015
Q1 | $126K | Buy |
|
|||||
|
2014
Q4 | $249K | Buy |
|
|||||
|
2014
Q3 | $42K | Buy |
|
|||||
|
2014
Q2 | $18K | Buy |
|